Sixfold Bioscience

It's the day after the SAE RNA Therapeutics conference in London and after a great meeting, I am reflecting Sixfold's aspirations, on making and strengthening our collaboration networks and on being a member of the RNA therapeutics community in general. It was a great opportunity to outline what Sixfold Bioscience does, what we want to do more of and how we work to make the connections to those who want to join us on the journey. And I am already looking forward to the next time I get to stand on the stage, and reveal even more about what Sixfold can do. #Sixfold #SAE #RNAi #Drugdelivery

Next week Dr Søren Ottosen, VP of Research, will be at the RNA Therapeutics Conference to present our work on RNA delivery. Read more: https://lnkd.in/eqJDd_PF SAE Media Group Pharma #RNADelivery #Oligonucleotides

Next week Tina, George and Anna will be in San Francisco for the 43rd Annual J.P. Morgan Healthcare Conference, taking place from the 13-16 January. We're looking forward to connecting with life sciences innovators to discuss opportunities to support the advancement of RNA therapeutics and delivery. If you're attending and would like to connect with the team in San Francisco, please connect with us. #JPM #JPM2025 #RNA #DrugDelivery

Huge thanks to @Steve Bates Martin Turner and all the #BIA team for BioIndustry Association Parliament Day 2024. This is such an impactful time for engaging with Government and the political-fiscal landscape for our industry, particularly as we ride the double edged challenges of tough financing and the greatest technology-meets-biology opportunities ever seen. I deeply appreciated the contributions of all, who raised important and timely points from across our shared sector - also nice to see you there Melissa Strange Paul Varley Kristen Albright Sam Whitehouse Alistair Milnes Will Milligan Euan Cameron Robert Tansley

Søren Ottosen, VP Research, will be in London for the RNA Therapeutic UK Conference on February 10-11, 2025. His panel session will be covering recent advances in RNA modalities (expect a good dose of #RNADelivery!).

🌟 What an inspiring event! 🌟 A huge thank you to everyone who joined us for the Health & Life Sciences Networking Event connecting Scale Space and I-HUB innovators with Imperial’s clinical academics with the support of the NIHR Research Support Service and Gareth O'Brien. I-HUB's Reeta Daswani and Lara F. Scofano from Sixfold Bioscience presented, alongside Melis Eda Ekinci from Woost, Ali Ahmed Diaz from Blue Beagle Bio, and Heme Health. 🍕 And of course, networking over pizzas and drinks made the conversations even better! 🍕🥂 Looking forward to seeing future collaborations! #IHUB #collaboration #community

Yesterday, Dr Piotr Klimkowski presented our work in deploying HT automated chemistry to build and design better #RNA delivery systems. Its great to see the cutting-edge innovation happening in the UK around oligonucleotide technologies! From RNA-based immunotherapy breakthroughs to high-throughput automated delivery systems, the advancements being discussed at today’s event are shaping the future of biotech. A big thanks to CatSci Ltd for organising! Excited to see where these groundbreaking developments take us! #RNA #Oligonucleotides #UKInnovation #Biotech #CatSci Event: 'UK Innovation: The Future of RNA Therapeutics'  Presentation Title: 'A High-Throughput Automated Hit-to-lead approach for targeted RNA delivery' Location: Cardiff, UK Date: November 5th

Last day at DIA/FDA Oligonucleotide Therapeutics Conference: Going from idea to drug takes a whole lotta steps. Getting smarter and hearing about the hurdles and short-cuts in development beyond the first heureka moment is key for small biotech. Sixfold Bioscience #Oligo24 #oligonucleotides #OSWG

Last months team day involved exploring Windsor by land and river! A short train ride from our London labs, Windsor castle provided the perfect backdrop to celebrate the big wins and look forward to whats next 🛶 👑

Next week Sixfold is in Washington for the DIA/FDA Oligonucleotide-Based Therapeutics Conference.